Drug Shortage Report for ALFUZOSIN
Report ID | 65688 |
Drug Identification Number | 02414759 |
Brand name | ALFUZOSIN |
Common or Proper name | ALFUZOSIN |
Company Name | PRO DOC LIMITEE |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | ALFUZOSIN HYDROCHLORIDE |
Strength(s) | 10MG |
Dosage form(s) | TABLET (EXTENDED-RELEASE) |
Route of administration | ORAL |
Packaging size | 100 |
ATC code | G04CA |
ATC description | DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | |
Actual start date | 2018-10-29 |
Estimated end date | |
Actual end date | 2018-11-30 |
Shortage status | Resolved |
Updated date | 2018-12-01 |
Company comments | Discontinued |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2925 BOULEVARD INDUSTRIEL LAVAL, QUEBEC CANADA H7L 3W9 |
Company contact information | 2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2018-10-29 | English | Compare |
v2 | 2018-10-29 | French | Compare |
v3 | 2018-10-30 | English | Compare |
v4 | 2018-11-30 | English | Compare |
v5 | 2018-11-30 | French | Compare |
v6 | 2018-12-01 | English | Compare |
Showing 1 to 6 of 6